Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si-Yeon Lee

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Expert Opinion on Biological Therapy|December 14, 2018
Mechanism of action of the trastuzumab biosimilar CT-P6Sun Ah Jeong, Jung Min Choi, Jun Mo Park, et al.
Cancer Immunology Research|January 21, 2022
The Pellino1-PKCθ Signaling Axis Is an Essential Target for Improving Antitumor CD8+ T-lymphocyte FunctionJihyun Park, Si-Yeon Lee, Yoon Jeon, et al.
Cancer Immunology Research|August 12, 2024
The CCR6-CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in TumorsAyush Pant, Aanchal Jain, Yiyun Chen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Expert Opinion on Biological Therapy|December 14, 2018
Mechanism of action of the trastuzumab biosimilar CT-P6Sun Ah Jeong, Jung Min Choi, Jun Mo Park, et al.
Cancer Immunology Research|January 21, 2022
The Pellino1-PKCθ Signaling Axis Is an Essential Target for Improving Antitumor CD8+ T-lymphocyte FunctionJihyun Park, Si-Yeon Lee, Yoon Jeon, et al.
Cancer Immunology Research|August 12, 2024
The CCR6-CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in TumorsAyush Pant, Aanchal Jain, Yiyun Chen, et al.
Pageof 2